Sterility tested twice, by different methods
This is the part that separates Peptidology from everything else we have audited.
Each lot is screened by a compendial USP method at Vanguard Laboratory and by a ScanRDI rapid-detection method at Eagle Analytical Services.
Both must pass before the lot ships.
The two methods have different failure modes. The compendial standard carries regulatory weight. The rapid method catches viable cells the classical method can miss. Running one is uncommon in this market. Running both is unique to Peptidology among the suppliers we track.
The assays almost nobody else runs
Residual solvents. Sixteen analytes by GC-MS, all non-detect. Synthesis-stage contamination that nothing else in a standard panel would find.
Trifluoroacetic acid. Non-detect by ion chromatography at a 0.10% limit of quantitation. TFA is used in HPLC purification of peptides, carries over into the finished product, and is a documented confound in cell-based assays.
No other supplier we track tests for it.
Container closure integrity. Three of three vials pass by dye ingress, which evidences the sterility result rather than asserting it. A sterile fill in a compromised container is not sterile on arrival.
Solubility. Three of three vials fully soluble in 2 mL water. Functional quality control confirming the vial reconstitutes as specified.
Batch history is published
The product page carries a batch selector. For CJC-1295 No DAC, two lots are shown, March and June 2026, with an average purity of 99.55% across a range of 99.3 to 99.8 percent and 100 percent conformity.
A supplier publishing its own batch-to-batch variance is unusual. Most publish the best certificate and leave it there.